Jadran-Galenski Laboratorij (JGL) is the leading national company in the pharmaceutical and healthcare sector. It stands out as an advocate for corporate responsibility, actively promoting sustainable practices both within its operations and beyond.

This commitment is evident in several key areas:

• Management Leadership: JGL’s management team actively promotes CSR not only within the company but also through leadership roles in external organisations. This dedication is reflected in their award-winning sustainability performance.
• Dedicated ESG Roles: Recognising the potential for bias in CSR reporting, JGL has established dedicated ESG positions to ensure objective reporting on various aspects of sustainability.
• Comprehensive reporting: JGL publishes annual reports that integrate financial results, sustainability efforts and audits, aligned with global standards.
• Alignment with United Nations Goals: JGL strategically integrates the United Nations Sustainable Development Goals (SDGs) into its operations, focusing on areas such as health, gender equality and responsible consumption. JGL aims to operate in line with the Sustainable Development Goals (SDGs), thereby contributing to addressing global climate and social challenges and ensuring a better future for upcoming generations.

In 2021, the company established a long-term business strategy supported by three pillars, one of which is directly related to the impact of climate change. In 2023, a corporate project was implemented specifically tied to ESG goals, along with a system to monitor their implementation – the Group ESG Manager. Through their Code of Ethics, relief efforts in Ukraine, and the use of renewable energy sources. JGL’s commitment to ESG principles demonstrates that companies can integrate sustainability into their core business practices, contributing to a more responsible future.